Search

everythinglearnresearchcommunity

for

Search:↓

20(S)-Protopanaxadiol-aglycone may help prevent and treat prostate cancer by reducing androgen receptor activity.

5-alpha-reductase inhibitors significantly affect the penile tissue of hypertensive rats.

Finasteride may cause sexual and psychological side effects by affecting an enzyme related to epinephrine.

Reducing PEDF may help treat hair loss.

Prostaglandin D2 increases testosterone production in skin cells through a process involving reactive oxygen species, and antioxidants may help treat hair loss.

The inhibitor DPP can promote hair growth.

Mutations in the DSG4 gene cause fragile, sparse hair in humans, mice, and rats.

A vaccine may prevent benign prostatic hyperplasia (BPH).

The enzyme for activating vitamin D is found in many body tissues, not just the kidneys.

Two new mutations in the CDH3 gene cause hair loss and vision problems in a young girl.

Prostaglandin D2, found in higher levels in bald scalps, stops hair growth, suggesting that blocking its receptor could potentially treat hair loss.

Prostaglandin D2 increases testosterone production in skin cells through a process involving reactive oxygen species, which could be a new target for treating hair loss and other skin conditions driven by testosterone.

Scientists identified three genes important for processing certain brain chemicals, thyroid hormones, and medications.

A compound from brown algae boosts the production of a certain inflammatory substance in skin cells.

Two enzymes regulate androgen receptor activity, affecting treatments for androgen insufficiency and benign prostatic hyperplasia.

LPA3 signaling in the uterus is crucial for placental formation and fetal development.

GI198745 is more potent and longer-lasting than finasteride, potentially better for treating hair loss.

14,15-EET may help reduce poststroke pain by affecting certain brain proteins.

A new DSG4 gene mutation causes hair defects in a young girl.

The enzyme CD73 helps control human hair growth and could be targeted to treat hair growth disorders.

Finasteride reduces certain behaviors caused by D1-like receptor agonists but not by D2-like receptor agonists in mice.

The vitamin D receptor can regulate genes and affect hair and hormone levels without its usual activator.

A rare genetic mutation causes resistance to vitamin D, leading to severe rickets and requiring high doses of calcium and vitamin D for treatment.

The new compound is a promising, less toxic alternative to finasteride for treating prostate issues.

These medications for BPH have known risks and may have new side effects.

Androgen increases VEGF expression but not VEGFR-2 in rat corpus cavernous.

Blocking Prostaglandin D₂ may help treat hair loss.

Cadd4 effectively reduces cholesterol levels without side effects.

These medications for BPH have known risks and may have new side effects.